Atara Biotherapeutics
ATRA
ATRA
124 hedge funds and large institutions have $1.7B invested in Atara Biotherapeutics in 2018 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 60 increasing their positions, 29 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0% more capital invested
Capital invested by funds: $1.7B → $1.7B (+$5.06M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.27% less ownership
Funds ownership: 4.49% → 4.23% (-0.27%)
Holders
124
Holding in Top 10
3
Calls
$14.4M
Puts
$12M
Top Buyers
| 1 | +$32.4M | |
| 2 | +$29.4M | |
| 3 | +$19.1M | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$12.2M |
| 5 |
Goldman Sachs
New York
|
+$9.15M |
Top Sellers
| 1 | -$11.6M | |
| 2 | -$9.19M | |
| 3 | -$7.05M | |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$6.58M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$4.35M |